About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Phoenix | 146 Studies

Clinical Trials COPDPhoenix

COPD Clinical Trials in Phoenix

Find 146 clinical trials for copd near Phoenix, Arizona. Connect with research centers in your area.

All COPD trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 146 trials

CompletedBiologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous StudyThe purpose of the study is to evaluate the efficacy and safety of the 20 mL BLVR System in patients with homogeneous emphysema.NCT00630227·Birmingham, Alabama and 7 others CompletedComparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary DiseaseDirect comparison studies of the tiotropium HandiHaler® 18 µg and Respimat® 5 µg formulations have been limited to 4-week crossover studies.NCT01126437·Athens, Alabama and 1190 others

PreviousPage 4 of 8Next

COPD Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.This study evaluates the effect of two medicines on COPD (Chronic Obstructive Pulmonary Disease) exacerbations.NCT00144911·Birmingham, Alabama and 96 others

CompletedProcalcitonin Antibiotic Consensus Trial (ProACT)The ProACT study is a 5 year, multicenter study that will test the effect of implementation of a novel procalcitonin guideline on antibiotic use and adverse outcomes in Emergency…NCT02130986·Birmingham, Alabama and 12 others

CompletedA Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients.The objective of this study is to evaluate the efficacy and safety of 12 weeks treatment with tiotropium HandiHaler 18 micrograms (mcg) daily compared to Combivent Metered Dose…NCT00359788·Birmingham, Alabama and 30 others

Active not recruitingEvaluation of the Safety and Efficacy of TLD in Patients with COPDThe purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System (Nuvaira System) in the treatment of COPD.NCT03639051·Birmingham, Alabama and 32 others

CompletedEfficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)This study was designed to provide 12 weeks efficacy and safety data of the 150 μg once-daily (od) dose of indacaterol in chronic obstructive pulmonary disease (COPD).NCT00624286·Anniston, Alabama and 119 others

CompletedRespimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)The primary objective of this study is to compare the effect of ipratropium bromide/salbutamol inhalation spray combination administered by the Respimat® inhaler (20 mcg/100 mcg)…NCT00400153·Birmingham, Alabama and 179 others

CompletedStudy In Subjects With COPD (Chronic Obstructive Pulmonary Disease)This study was designed to determine if the investigational drug is effective and safe in individuals with COPD (chronic pulmonary disease)NCT00103922·Birmingham, Alabama and 114 others

CompletedEfficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary DiseaseThis study assessed the efficacy and safety of indacaterol (150 µg once daily \[od\]) when combined with tiotropium (18 µg od) versus tiotropium (18 µg od) treatment alone in…NCT00877383·Anniston, Alabama and 175 others

CompletedEfficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsThe purpose of this Phase III study is to evaluate the efficacy and safety of tozorakimab Dose 1 and Dose 2 administered subcutaneously (SC) in adult participants with symptomatic…NCT05166889·Huntsville, Alabama and 211 others

SuspendedZofin to Treat Chronic Obstructive Pulmonary Disease (COPD)A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion (IV) of Zofin for the Treatment of Chronic Obstructive…NCT05643729·Phoenix, Arizona

CompletedStudy to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPDThis is a Phase III randomized, double-blind, parallel group, multi-center, 24-week lung function study with BFF MDI (320/9.6 μg and 160/9.6 μg) compared to FF MDI 9.6 μg, BD MDI…NCT02766608·Athens, Alabama and 258 others

CompletedA Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPDThe purpose of this study is to evaluate the efficacy and safety of ensifentrine in patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).NCT04535986·Peoria, Arizona and 121 others

CompletedA Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary DiseaseThis an initial proof of concept, phase to study to assess the safety and efficacy of tofimilast for the chronic maintenance treatment of adults with Chronic Obstructive Pulmonary…NCT00219622·Phoenix, Arizona and 39 others

CompletedA Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD PatientsThe purpose of this study is to compare a combination asthma drug (Symbicort) with its two components, budesonide and formoterol, taken individually or in combination, and with…NCT00206154·Birmingham, Alabama and 211 others

CompletedBronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume ReductionTo assess the safety and efficacy of BTVA for the treatment of patients with heterogeneous upper lobe emphysema.NCT01041586·Phoenix, Arizona and 3 others

CompletedEffect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.The primary objective of this trial is to investigate the effect of 6 weeks treatment with tiotropium + olodaterol fixed dose combination inhalation solution on lung…NCT01533935·Phoenix, Arizona and 32 others

UnknownSeasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary DiseaseTo evaluate the magnitude of the humoral immune responses to quadrivalent vs trivalent influenza vaccines in adults between the age of 50 and 64 years with a prior diagnosis of…NCT02563184·Phoenix, Arizona

CompletedEfficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38)The purpose of this study is to evaluate the efficacy, safety and tolerability of aclidinium bromide doses compared with placebo in the treatment of moderate to severe, stable…NCT01045161·Birmingham, Alabama and 111 others

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia